Potential Physiological Convergence Between GLP-1 Receptor Signaling and Hepatocyte TAZ in Metabolic Liver Disease: From Metabolic Homeostasis to Fibrotic Remodeling

Mohammed F. Gholam · 2026

Read Potential Physiological Convergence Between GLP-1 Receptor Signaling and Hepatocyte TAZ in Metabolic Liver Disease: From Metabolic Homeostasis to Fibrotic Remodeling by Mohammed F. Gholam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13664139.txt.

Description

Mohammed F Gholam, writing alone, weighs whether two liver pathways converge in metabolic liver disease in this 2026 review. Fatty liver disease advances when overfeeding, insulin resistance, and cell stress overwhelm the liver. GLP-1 drugs trim weight and calm liver inflammation in trials.

In parallel, a protein called TAZ senses nutrients and stiffness in liver cells and drives scarring. Gholam maps both systems across gut, fat, pancreas, and liver cell types. Fresh proof shows one drug can signal through liver vessel receptors without weight loss. Whether TAZ sits downstream of that signal remains unproven. The review frames a convergence model as a testable idea, not a settled fact.

Catalog record

CREATORMohammed F. Gholam
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13664139

Browse the full library · About the Tower of Babel